Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven Kyle Grinspoon, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Steven Grinspoon and Takara Stanley.
Steven Grinspoon
Connection Strength
13.076
Takara Stanley
  1. Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 08 16; 73(4):621-630.
    View in: PubMed
    Score: 0.979
  2. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2021 01 23; 106(2):e520-e533.
    View in: PubMed
    Score: 0.942
  3. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019 12; 6(12):e821-e830.
    View in: PubMed
    Score: 0.861
  4. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Horm IGF Res. 2015 Apr; 25(2):59-65.
    View in: PubMed
    Score: 0.617
  5. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014 Jul 23-30; 312(4):380-9.
    View in: PubMed
    Score: 0.597
  6. Body composition and metabolic changes in HIV-infected patients. J Infect Dis. 2012 Jun; 205 Suppl 3:S383-90.
    View in: PubMed
    Score: 0.517
  7. Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. Clin Infect Dis. 2012 Jun; 54(11):1642-51.
    View in: PubMed
    Score: 0.512
  8. Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction. AIDS. 2011 Jun 19; 25(10):1281-8.
    View in: PubMed
    Score: 0.484
  9. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab. 2011 Jan; 96(1):E146-50.
    View in: PubMed
    Score: 0.464
  10. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J Clin Endocrinol Metab. 2011 Jan; 96(1):150-8.
    View in: PubMed
    Score: 0.462
  11. Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients. AIDS. 2009 Jul 17; 23(11):1349-57.
    View in: PubMed
    Score: 0.424
  12. GH/GHRH axis in HIV lipodystrophy. Pituitary. 2009; 12(2):143-52.
    View in: PubMed
    Score: 0.408
  13. Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 06 15; 72(12):2087-2094.
    View in: PubMed
    Score: 0.242
  14. Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Sci Rep. 2021 05 18; 11(1):10485.
    View in: PubMed
    Score: 0.241
  15. Reply to Maurice and Lemoine. Clin Infect Dis. 2021 03 01; 72(5):909.
    View in: PubMed
    Score: 0.237
  16. Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI Insight. 2020 08 20; 5(16).
    View in: PubMed
    Score: 0.229
  17. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach. J Infect Dis. 2020 08 17; 222(6):929-939.
    View in: PubMed
    Score: 0.228
  18. Association of In Utero HIV Exposure With Obesity and Reactive Airway Disease in HIV-Negative Adolescents and Young Adults. J Acquir Immune Defic Syndr. 2020 02 01; 83(2):126-134.
    View in: PubMed
    Score: 0.220
  19. Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV. Nutr Diabetes. 2019 02 25; 9(1):6.
    View in: PubMed
    Score: 0.206
  20. Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial. J Clin Endocrinol Metab. 2018 11 01; 103(11):4176-4186.
    View in: PubMed
    Score: 0.202
  21. Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV. J Clin Endocrinol Metab. 2018 06 01; 103(6):2376-2384.
    View in: PubMed
    Score: 0.196
  22. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS. 2018 04 24; 32(7):927-932.
    View in: PubMed
    Score: 0.195
  23. Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV. AIDS. 2017 10 23; 31(16):2253-2259.
    View in: PubMed
    Score: 0.188
  24. Differential relationships of hepatic and epicardial fat to body composition in HIV. Physiol Rep. 2017 Oct; 5(19).
    View in: PubMed
    Score: 0.188
  25. Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation. Growth Horm IGF Res. 2017 12; 37:1-6.
    View in: PubMed
    Score: 0.187
  26. Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices During HIV Infection. J Infect Dis. 2016 Nov 01; 214(9):1336-1340.
    View in: PubMed
    Score: 0.173
  27. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial. J Clin Endocrinol Metab. 2016 Mar; 101(3):1123-33.
    View in: PubMed
    Score: 0.165
  28. RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients. J Clin Endocrinol Metab. 2015 Aug; 100(8):2873-82.
    View in: PubMed
    Score: 0.160
  29. Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity. Growth Horm IGF Res. 2014 Feb; 24(1):10-5.
    View in: PubMed
    Score: 0.143
  30. Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size. Clin Endocrinol (Oxf). 2012 Feb; 76(2):220-7.
    View in: PubMed
    Score: 0.126
  31. Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3. J Clin Endocrinol Metab. 2011 Jul; 96(7):E1153-8.
    View in: PubMed
    Score: 0.120
  32. Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor. Growth Horm IGF Res. 2011 Jun; 21(3):155-9.
    View in: PubMed
    Score: 0.120
  33. Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults. Diabetes Care. 2011 Apr; 34(4):1026-31.
    View in: PubMed
    Score: 0.119
  34. The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men. J Clin Endocrinol Metab. 2011 Mar; 96(3):817-23.
    View in: PubMed
    Score: 0.117
  35. Increased skeletal muscle phosphocreatine recovery after sub-maximal exercise is associated with increased carotid intima-media thickness. Atherosclerosis. 2011 Mar; 215(1):214-7.
    View in: PubMed
    Score: 0.117
  36. The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men. Clin Endocrinol (Oxf). 2010 Nov; 73(5):622-9.
    View in: PubMed
    Score: 0.116
  37. Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation. Clin Endocrinol (Oxf). 2010 Jul; 73(1):48-54.
    View in: PubMed
    Score: 0.113
  38. Skeletal muscle phosphocreatine recovery after submaximal exercise in children and young and middle-aged adults. J Clin Endocrinol Metab. 2010 Sep; 95(9):E69-74.
    View in: PubMed
    Score: 0.113
  39. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab. 2009 Dec; 94(12):4875-81.
    View in: PubMed
    Score: 0.108
  40. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. J Clin Endocrinol Metab. 2009 Dec; 94(12):5131-8.
    View in: PubMed
    Score: 0.108
  41. Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects. Metabolism. 2009 May; 58(5):608-15.
    View in: PubMed
    Score: 0.104
  42. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008 Nov; 93(11):4254-60.
    View in: PubMed
    Score: 0.100
  43. Racial and ethnic representation among a sample of nutrition- and obesity-focused professional organizations in the United States. Obesity (Silver Spring). 2021 Oct 18.
    View in: PubMed
    Score: 0.062
  44. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab. 2001 Sep; 86(9):4120-6.
    View in: PubMed
    Score: 0.061
  45. Tesamorelin improves fat quality independent of changes in fat quantity. AIDS. 2021 07 15; 35(9):1395-1402.
    View in: PubMed
    Score: 0.061
  46. Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J Appl Physiol (1985). 2001 Jun; 90(6):2166-71.
    View in: PubMed
    Score: 0.060
  47. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab. 2001 Feb; 86(2):504-10.
    View in: PubMed
    Score: 0.059
  48. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001 Jan; 32(1):130-9.
    View in: PubMed
    Score: 0.058
  49. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis. 2000 Nov; 31(5):1240-4.
    View in: PubMed
    Score: 0.058
  50. Comparison of total body potassium with other techniques for measuring lean body mass in men and women with AIDS wasting. Am J Clin Nutr. 2000 Oct; 72(4):1053-8.
    View in: PubMed
    Score: 0.058
  51. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med. 2000 Sep 05; 133(5):348-55.
    View in: PubMed
    Score: 0.057
  52. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab. 2000 Jan; 85(1):35-41.
    View in: PubMed
    Score: 0.055
  53. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab. 2000 Jan; 85(1):60-5.
    View in: PubMed
    Score: 0.055
  54. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting. Clin Infect Dis. 1999 Mar; 28(3):634-6.
    View in: PubMed
    Score: 0.052
  55. Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab. 1999 Jan; 84(1):201-6.
    View in: PubMed
    Score: 0.051
  56. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab. 1998 Dec; 83(12):4251-6.
    View in: PubMed
    Score: 0.051
  57. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 May 15; 64(10):1422-1429.
    View in: PubMed
    Score: 0.046
  58. Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus. Open Forum Infect Dis. 2017; 4(2):ofx083.
    View in: PubMed
    Score: 0.045
  59. Associations between plasma branched-chain amino acids, ß-aminoisobutyric acid and body composition. J Nutr Sci. 2016; 5:e6.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.